Skip to content

Sinovation Ventures

Request correction

Sinovation Ventures is a leading Chinese technology venture capital firm founded by a team led by Dr. Kai-Fu Lee in 2009.

Last updated September 15, 2026

AI crawler reads

2requests

1companies
  • Anthropic2
Profile
2
Controversies
0
JSON · MD
0
First read
Nov 4, 2026
Latest read
Nov 4, 2026

From this site's server log

Overview

Sinovation Ventures is a leading Chinese technology venture capital firm. Founded by a team led by Dr. Kai-Fu Lee in 2009, it manages ten USD- and RMB-denominated funds with over US$3 billion in assets under management, backing more than 500 portfolio companies across technology and innovation globally. Its stated aim is to help Chinese entrepreneurs build world class companies.

History

Sinovation Ventures is a leading Chinese technology venture capital firm. It was founded by a team led by Dr. Kai-Fu Lee in 2009. The firm manages ten USD- and RMB-denominated funds with over US$3 billion in assets under management, and has backed more than 500 portfolio companies across technology and innovation globally. Its stated mission is to help Chinese entrepreneurs build world class companies.

Products and positioning

Leading Chinese technology venture capital firm; aims to help Chinese entrepreneurs build world class companies.

Recent events

  • Reported

    Jingzhan Semiconductor completes B+ strategic funding round[2]

    Jingzhan Semiconductor announced that it had completed a B+ strategic funding round worth several hundred million yuan, led by Goertek Microelectronics, with other investors participating. The proceeds are mainly intended for construction of the company's headquarters and R&D center.

  • Reported

    Tomato Pocket completes Series A funding[3]

    Tomato Pocket completed a 50 million yuan Series A funding round, with Innovation Works as the sole investor. The company said the funds would mainly support nationwide offline-store expansion, brand building and talent recruitment.

  • Unconfirmed

    Reported

    OnQuality Pharmaceuticals completes $20 million Series A+ financing[4]

    OnQuality Pharmaceuticals announced that it had recently completed a $20 million Series A+ financing. The company said the funds would support a Phase II clinical trial in the United States and development of four further projects planned for clinical testing within 18 months.

  • Unconfirmed

    Reported

    4B Technologies completes A++ funding round[5]

    4B Technologies (福贝生物) announced that it completed an A++ funding round led by Gaorong Capital, with participation from Fengchuan Capital, Qingyuan Capital, Innovation Works, Huachuang Capital, and Fukun Capital, among others.

  • Reported

    Aikenuo completes A2 funding round[6]

    Aikenuo announced that it completed an A2 funding round of nearly RMB 100 million, led by Innovation Works. The funds are mainly for clinical trials, NMPA registration applications, and production transition for its instruments and reagents.

  • Reported

    Moqun completes angel funding round[7]

    Moqun announced that it had completed an angel funding round, receiving several million US dollars in investment from Innovation Works and individual investors.

  • Beiden Medical completes Series B funding[8]

    Beiden Medical announced that it had completed a Series B financing round worth more than RMB 100 million, led by Innovation Works.

  • Reported

    Kua-tu Logistics completes Series B funding[9]

    Kua-tu Logistics announced that it completed Series B funding led by Zhongwei Capital, with Country Garden Ventures participating and existing shareholders including Innovation Works and Alto Investment continuing to invest. The proceeds were primarily intended for national market expansion, product upgrades and technology research and development.

Read more

Sources11 sources

Cite this profile: Cite the canonical profile. /brand-wiki/sinovation-ventures · Editorial policy · How profiles are compiled